TPE:6919 Revenue

Caliway Biopharmaceuticals had revenue of 2.00K TWD in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 38.04M, down -6.00% year-over-year. In the year 2025, Caliway Biopharmaceuticals had annual revenue of 38.04M, down -14.40%.

Revenue (ttm)

38.04M

Revenue Growth

-6.00%

P/S Ratio

4,132.42

Revenue / Employee

n/a

Employees

n/a

Market Cap

157.19B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.04M	-6.40M	-14.40%
Dec 31, 2024	44.43M	5.50M	14.13%
Dec 31, 2023	38.93M	26.11M	203.68%
Dec 31, 2022	12.82M	481.00K	3.90%
Dec 31, 2021	12.34M	1.99M	19.22%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Pell Bio-Med Technology	31.42M
Oneness Biotech	129.12M
Sunmax Biotechnology	2.03B
Lumosa Therapeutics	35.83M
AP Biosciences	32.25M
Medigen Vaccine Biologics	613.17M
Polaris Group	40.60M
EirGenix	1.01B

Revenue Rankings